{
  "type": "periodic transaction",
  "title": "Periodic Transaction Report for 12/06/2017",
  "filer": "The Honorable Michael D Crapo (Crapo, Michael D.)",
  "filed-date": "12/06/2017",
  "filed-time": "5:30 PM",
  "calendar-year": null,
  "data-entry-complete": true,
  "data": [
    {
      "heading": "Transactions",
      "amended": false,
      "rows": [
        {
          "transaction-date": "11/27/2017",
          "owner": "Joint",
          "ticker": "--",
          "asset-name": "Pharma Partners, LLC\n                                        \n                                        \n                                        \n                                            \n                                                \n                                                    Company: Pharma Partners, LLC\n                                                    \n                                                         (Englewood, CO)\n                                                    \n                                                \n                                            \n\n                                            \n                                                Description: The LLC funds research and clinical trials on a new class of drugs, metalloporphyrins. The lead drugs are BMX-010 and BMX-001.",
          "asset-type": "Other Securities",
          "type": "Purchase",
          "amount": "$50,001 - $100,000",
          "comment": "Investment in LLC."
        }
      ]
    }
  ]
}